INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
08/08/2023
Voltar para busca
Dado oficial do USPTO
SPEEDX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
08/08/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10
Data de depósito
07/01/2011
Data de registro
29/05/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/11/2022
Última transação
09/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Eveleigh, AU
Examinador
ZAK, HENRY
Unidade examinadora
M80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
SpeeDx Pty Ltd
SpeeDx Pty Ltd
Representantes
Mainak Mehta Procopio, Cory, Hargreaves and Savitch LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemicals used in industrysciencephotography; chemicals used in agriculturehorticulture and forestry except fungicidesherbicidesinsecticidesparasiticides; chemical reagents and reactants for non-medical purposes; enzymes for use in the biotechnology industry; nucleic acid sequencesother than medical and veterinary purposes; nucleic recombinant acids; nucleic acids; DNA polymeraseother than medical and veterinary purposes; chemicals used in food processing and screening; microbial chemicals used in environmental monitoring
Classe 5
pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceuticalveterinary and medical purposes; medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Classe 10
surgical and medical apparatus and instrumentssurgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposesfor the detection of diseasesdetection and identification of pathogensdetection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypingfor analysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/07/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/11/2022
71AG
REGISTERED-SEC.71 ACCEPTED
09/11/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2022
ES71
TEAS SECTION 71 RECEIVED
30/05/2022
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29/05/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
28/01/2021
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
01/11/2019
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
19/09/2019
INPC
INVALIDATION PROCESSED
19/09/2019
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/09/2019
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
08/01/2019
71AG
REGISTERED-SEC.71 ACCEPTED
08/01/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/01/2019
ES71
TEAS SECTION 71 RECEIVED
09/11/2018
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/05/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/03/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/02/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/12/2016
GPNX
NOTIFICATION PROCESSED BY IB
25/11/2012
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/09/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/09/2012
FIMP
FINAL DISPOSITION PROCESSED
10/09/2012
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/08/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
29/05/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/03/2012
PUBO
PUBLISHED FOR OPPOSITION
13/03/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/02/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/02/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/02/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/02/2012
ALIE
ASSIGNED TO LIE
01/02/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/01/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/01/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2012
RFNP
REFUSAL PROCESSED BY IB
18/09/2011
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
31/08/2011
RFRR
REFUSAL PROCESSED BY MPU
31/08/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/08/2011
CNRT
NON-FINAL ACTION WRITTEN
30/08/2011
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
30/08/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/08/2011
CNRT
NON-FINAL ACTION WRITTEN
29/08/2011
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
29/08/2011
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/08/2011
CNRT
NON-FINAL ACTION WRITTEN
26/08/2011
MAFR
APPLICATION FILING RECEIPT MAILED
23/08/2011
DOCK
ASSIGNED TO EXAMINER
19/08/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2011
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/08/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SPEEDX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.